Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
142.42B
Market cap142.42B
Price-Earnings ratio
51.41
Price-Earnings ratio51.41
Dividend yield
Dividend yield
Average volume
10.72M
Average volume10.72M
High today
$96.48
High today$96.48
Low today
$95.55
Low today$95.55
Open price
$95.98
Open price$95.98
Volume
2.02M
Volume2.02M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$85.98
52 Week low$85.98

Stock Snapshot

Boston Scientific(BSX) stock is priced at $96.48, giving the company a market capitalization of 142.42B. It carries a P/E multiple of 51.41.

As of 2025-12-25, Boston Scientific(BSX) stock has fluctuated between $95.55 and $96.48. The current price stands at $96.48, placing the stock +1.0% above today's low and 0.0% off the high.

Boston Scientific(BSX) shares are trading with a volume of 2.02M, against a daily average of 10.72M.

In the last year, Boston Scientific(BSX) shares hit a 52-week high of $109.50 and a 52-week low of $85.98.

In the last year, Boston Scientific(BSX) shares hit a 52-week high of $109.50 and a 52-week low of $85.98.

BSX News

Simply Wall St 10h
Does Boston Scientific’s Strong Run Match Its Current Valuation in 2025?

If you have been wondering whether Boston Scientific is still a smart buy after its big run in recent years, this breakdown will help you decide if the current...

Does Boston Scientific’s Strong Run Match Its Current Valuation in 2025?
Nasdaq 18h
BSX Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investo...

BSX Factor-Based Stock Analysis - Peter Lynch
TipRanks 20h
Boston Scientific’s Global Pulsed Field Ablation Trial Targets Persistent Atrial Fibrillation Growth

Boston Scientific (BSX) announced an update on their ongoing clinical study. Claim 70% Off TipRanks This Holiday Season Unlock hedge-fund level data and powerfu...

Analyst ratings

94%

of 36 ratings
Buy
94.4%
Hold
5.6%
Sell
0%

More BSX News

Nasdaq 23h
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth?

Boston Scientific’s BSX Endoscopy business is a core component of its MedSurg segment, developing and manufacturing devices to diagnose and treat a broad range...

How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth?
The Motley Fool 24h
Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors?

This basket of 64 medical device stocks could raise its dividend for decades. The healthcare sector came under pressure in 2025, as federal spending cuts slash...

TipRanks 3d
Belo Sun to Raise Up to US$30 Million in Private Placement Backed by La Mancha

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...

Simply Wall St 6d
Upgraded Outlook and New Institutional Interest Might Change The Case For Investing In Boston Scientific

In recent weeks, Boston Scientific reported strong Q3 2025 results, highlighting robust growth in its cardiovascular product lines and raising its adjusted 2025...

Upgraded Outlook and New Institutional Interest Might Change The Case For Investing In Boston Scientific
Nasdaq 7d
August 2026 Options Now Available For Boston Scientific

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the August 2026 expiration. One of the key data points that goes int...

August 2026 Options Now Available For Boston Scientific
TipRanks 7d
Boston Scientific price target lowered to $120 from $130 at Truist

Truist lowered the firm’s price target on Boston Scientific (BSX) to $120 from $130 and keeps a Buy rating on the shares as part of a broader research note prev...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.